Financials
- Market Capitalization 128.12 M
- Employee 21
- Founded 2014
- CEO N/A
- Website www.blackdiamondtherapeutics.com
- Headquarter Massachusetts, United States
- FIGI BBG00MS4Y0W9
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3811 | HURA TuHURA Biosciences, Inc. - Common Stock | 2.11 USD | -0.94% | +0.48% | 0.00% | -21.56% | 134.46 M USD | ||
| 3815 | INO Inovio Pharmaceuticals, Inc. - Common Stock | 1.29 USD | +2.38% | +8.40% | +76.71% | -45.11% | 133.38 M USD | ||
| 3833 | VANI Vivani Medical, Inc. - Common Stock | 1.42 USD | +1.43% | +1.43% | +10.94% | +24.56% | 128.09 M USD | ||
| 3834 | VTVT vTv Therapeutics Inc. - Class A Common Stock | 32.36 USD | -1.34% | -3.14% | -1.94% | +57.85% | 127.95 M USD |
Frequently asked questions about Black Diamond Therapeutics, Inc. Common Stock
What is the Black Diamond Therapeutics, Inc. Common Stock stock price today?
The current price of Black Diamond Therapeutics, Inc. Common Stock (BDTX) is 2.23. Over the past 24 hours, the stock has changed by -1.76%. Follow the BDTX chart for real-time price dynamics.
What is the stock ticker of Black Diamond Therapeutics, Inc. Common Stock?
Black Diamond Therapeutics, Inc. Common Stock trades under the ticker BDTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Black Diamond Therapeutics, Inc. Common Stock stock going up?
BDTX has changed by +0.45% over the last week, +32.74% over the last month, and -17.71% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Black Diamond Therapeutics, Inc. Common Stock?
Black Diamond Therapeutics, Inc. Common Stock currently has a market capitalization of 128.12 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Black Diamond Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Black Diamond Therapeutics, Inc. Common Stock reported earnings of -0.17 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Black Diamond Therapeutics, Inc. Common Stock revenue for the last quarter?
Black Diamond Therapeutics, Inc. Common Stock reported quarterly revenue of 0. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Black Diamond Therapeutics, Inc. Common Stock net income for the last quarter?
Black Diamond Therapeutics, Inc. Common Stock reported net income of -9.9 M for the last quarter. The previous quarter showed -9.04 M, which means net income changed by -9.62%.
How many employees does Black Diamond Therapeutics, Inc. Common Stock have?
As of the latest available data, Black Diamond Therapeutics, Inc. Common Stock has 21 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Black Diamond Therapeutics, Inc. Common Stock stock?
You can buy Black Diamond Therapeutics, Inc. Common Stock (BDTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Black Diamond Therapeutics, Inc. Common Stock stock?
Investing in Black Diamond Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BDTX chart and related analysis on metatrader.com as part of your research.